{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-032499","form_type":"8-K","ticker":"MLAB","cik":"0000724004","company_name":"MESA LABORATORIES INC /CO/","filed_at":"2026-10-13T12:00:11+00:00","discovered_at":"2026-10-13T12:05:00.276600+00:00","generated_at":"2026-10-13T12:05:44.463221+00:00","sec_items":["2.05","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.68,"calibrated_materiality_score":0.68,"confidence":"high","headline":"Mesa Laboratories approves restructuring cutting ~40 jobs, targets $9.3M annualized savings","bullets":["Board approved the Restructuring Program on October 6, 2026; ~40 positions eliminated (~6% of employees), concentrated in Clinical Genomics plus corporate functions.","Estimated pre-tax charges of $2.6M-$3.4M, including $2.3M-$3.0M employee costs; cash expenditures of $2.9M-$3.7M, mostly within 12 months.","Savings Plan targets ~$9.3M in annualized cost reductions with ~$4.3M reinvested, for a net ~$5.0M reduction fully reflected by end of FY2028.","Hamburg, Germany facility will be exited when its lease expires in February 2027; San Diego, California footprint also reduced.","CEO Siddhartha Kadia said Clinical Genomics will focus on pharmacogenomics and oncology at scale, accepting lower revenue for higher gross margin; Q2 FY2027 results set for November 9, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-032499","json":"https://secwatch.observer/filing/0001437749-26-032499.json","markdown":"https://secwatch.observer/filing/0001437749-26-032499.md","text":"https://secwatch.observer/filing/0001437749-26-032499.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/724004/000143774926032499/0001437749-26-032499-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/724004/000143774926032499/mlab20261013_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-13T12:05:44.463221+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}